Library Funding

The Scientist, Feb. 21, 1994, page 1), leave the wrong impression, I would like to emphasize that many of my consulting clients since 1981 have been not-for-profit organizations interested in achieving performance objectives in terms of the marketplace and their mission statements. No publisher, commercial or otherwise, dictated my writing or speech. I have openly disagreed with and criticized many publishers, such as the American P

Written byAlbert Henderson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I have openly disagreed with and criticized many publishers, such as the American Physical Society, when I believe they have failed the interests of their members, not without some reluctance and disappointment. My consulting services are for hire, not for sale.

If, after reading the comments of Association of Research Libraries spokeswoman Ann Okerson, any of your readers are interested in another librarian's point of view, they might like to read "The treason of the learned. The real agenda of those who would destroy libraries and books," by Michael Gorman, Dean of Library Services, California State University, Fresno (Library Journal, 119[3]:130-1, Feb. 15, 1994). His comments clarify why the typical university spends today half what it spent 25 years ago to keep its research collections up-to-date--and where the money goes.

ALBERT HENDERSON
Box 2423
Noble Station
Bridgeport, Conn. 06608-0423
E-mail: 70244.1532@compuserve.com

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies